To characterize mitogens that might contribute to Schwann cell proliferation during development or in tumors, we tested the ability of hepatocyte growth factor (HGF) to stimulate Schwann cell division in vitro. HGF is a potent mitogen for purified rat Schwann cells; DNA synthesis in rat Schwann cells was stimulated 20-40-fold by 3-10 rig/ml HGF. Rat Schwann cells express c-met mRNA, encoding the HGF receptor, but not HGF mRNA, implying that HGF might act as a paracrine Schwann cell growth factor. HGF-stimulated Schwann cell proliferation differs from that of previously described Schwann cell mitogens in that its activity is abolished by forskolin and is not inhibited or potentiated by addition of transforming growth factor /I (TGFB) or fibroblast growth factor (FGF). HGF is probably not a component of the axonal signal thought to cause Schwann cell division during development, as anti-HGF neutralizing antibodies failed to block neuron-stimulated Schwann cell proliferation. In contrast, mitogenic activity present in normal human adult nerves and in neurofibromas from patients with type 1 neurofibromatosis analyzed in the absence of forskolin is largely inhibitable by anti-HGF. Thus, HGF is a novel mitogen for Schwann cells in vitro and it is present in Schwann cell tumors, suggesting a potential role for HGF after wounding of peripheral nerves or in tumor growth.
[Key words: CAMP, f&rob/ad growth factor, transforming growth factor, NFl, c-met, HGF, Schwann cell, mitogen] Defining growth factors involved in Schwann cell proliferation is important in understanding interactions between Schwann cells and neurons in development, during nerve regeneration after wounding, and in formation of Schwann cell tumors. While adult Schwann cells are normally quiescent, high rates ofschwann cell division occur in the developing rat during the prenatal period after which proliferation falls gradually (Brown and Asbury, 198 1; Stewart et al., 1993) . Reentry into the cell cycle occurs after nerve injury (Abercrombie and Johnson, 1946; Pellegrino et al., 1986) and in Schwann cell tumors characteristic of the inherited diseases type 1 (NFl) and type 2 neurofibromatosis. In NFI, benign peripheral nerve tumors (neurotibromas) contain axons, fibroblasts, and matrix in addition to Schwann cells (Peltonen et al., 1988) . Mitogens for Schwann cells have been detected in both neurofibromas characteristic of NFl (Ratner et al., 1990) and in inherited and sporadic vestibular Schwannomas characteristic of NF2 (Brockes et al., 1986) . Neurofibromas contain basic fibroblast growth factor (bFGF) (Ratner et al., 1990 ) and insulin-like growth factor 2 (IGF-2) (Hansson et al., 1988) as well as an unidentified heparin-binding growth factor. The factors controlling Schwann cell proliferation in development or disease are unknown.
In vitro rat Schwann cells proliferate very slowly even in serum-containing medium. However, they can be stimulated to proliferate upon contact with the cell membrane ofaxon (Wood and Bunge, 1975; . The axonal mitogen has not been identified. Recently, a Schwann cell mitogen known as glial growth factor (GGF) has been purified, cloned, and sequenced (Lemke and Brockes, 1984; Goodearl et al., 1993; Marchionni et al., 1993) . Several forms of GGF are products of the neuregulin gene; neuregulin mRNA is highly enriched in neurons during development, suggesting the idea that one or more forms of neuregulin might be responsible for the ability of axons to stimulate Schwann cell division (Falls et al., 1993; Marchionni et al., 1993) . Several other identified polypeptide growth factors also act as Schwann cell mitogens in vitro, including transforming growth factors /31 and p2 (TGFPl and 2) acidic (aFGF) and basic (bFGF) fibroblast growth factors, platelet-derived growth factor (PDGF) (Ratner et al., 1988; Ridley et al., 1989; Davis and Stroobant, 1990; Eccleston et al., 1990; Stewart et al., 1991; Hardy et al., 1992; Ratner et al., 1988) . The action of each of these growth factors, and of neuregulin, is potentiated by forskolin or cholera toxin, agents elevating intracellular CAMP. To explain the dependence of Schwann cell mitogens on CAMP elevation in Schwann cells, it has been proposed that axonal contact might regulate CAMP levels in Schwann cells, enabling response to polypeptide growth factors (Jessen and Mirsky, 199 1) . CAMP treatment also increases levels of the PDGF receptor on Schwann cells in vitro (Weinmaster and Lemke, 1990) suggesting that potentiation of growth factor action may be through induction of this growth factor receptor.
In an attempt to characterize additional Schwann cell mitogens, we tested the ability of a broad specificity growth factor, hepatocyte growth factor (HGF), to stimulate Schwann cell pro-liferation.
HGF, also known as scatter factor or hepatopoietin A, was originally identified in the serum of hepatectomized rats as a potent mitogen for cultured hepatocytes (Nakamura et al., 1984) . HGF is present at high levels in normal rat serum (DeFrances et al., 1992) . HGF is a heteromeric protein composed of two polypeptide chains (69K n-chain and 34K P-chain) linked together by disulfide bonds. HGF shares significant amino acid sequence homology with plasminogen (38%), and the two proteins have structural similarity: both contain intrachain disulfide loops called "kringles."
HGF has four kringle domains in its a-chain (Nakamura et al., 1989) . The receptor for HGF is a 190 kDa protein, encoded by the protooncogene known as c-met (Bottaro et al., 199 1; Naldini et al., 1991 
Materials and Methods
Materials. DME, fetal calf serum, and 0.25% trypsin were obtained from GIBCO Laboratories, Grand Island, NY, forskolin, from Calbiothem-Behring Corp., San Diego, CA; basic and acidic FGF, TGF61, and TGFPZ, from R&D Systems, Minneapolis, MN; )H-thymidine (6.7 Ci/mmol), from New England Nuclear, Boston, MA.
Human tissue specimens. NFI tumor samples (plexiform and cutaneous) were obtained incidental to therapeutic surgery or at autopsy from eight patients ranging in age from 9 to 74 years, of both sexes, meeting the diagnostic criteria for NFI (Riccardi, 1992) . Normal human nerve specimens (n = 2) were obtained at autopsy or secondary to therapeutic amputation from the Cooperative Human Tissue Network, Midwest Division.
HGF and anti-HGF antisera. Recombinant HGF was prepared in a baculovirus expression system as described (Yee et al., 1993) . Polyclonal antibodies to rabbit and human recombinant HGF were prepared in chicken as described by Zamegar et al. (I 990) . These antisera were used for Schwann cell proliferation studies as described in the text.
Schwunn cellpurijication andproliferation assay. Schwann cells were prepared from I-2-d-old rat pup sciatic nerves using a slightly modified method of Brockes et al. (1979) (see Ratner et al., 1986) . After complement-mediated lysis of libroblasts, cells were plated into 96-well plastic dishes at IO4 cells/well in DMEM with 10% fetal calf serum. HGF, forskolin, or other growth factors were added 24-72 hr later in defined serum-free medium, N2. The final concentration of serum in the assay was 0.5%, and is referred to below as low-serum medium. 'Hthymidine at a concentration of 2 &?i/ml was added 16-19 hr later. Cells were fixed after an additional 24 hr by addition of ice-cold trichloroacetic acid, solubilized in NaOH, and counted in a scintillation counter, as described in Nordlund et al. (1992) .
Total RNA extraction and reverse-transcriptase polymerase chain rea&on (PCR). Total RNA was extracted from 11 x 10' Schwann cells, amplified from primary rat Schwann cells, as described by Porter et al. (1987) . by exposure to forskolin and serum on polylysine-coated plastic; GGF was replaced by bovine brain membrane extract (Nordlund et al., 1992) . The cells were homogenized using a Brinkmann Polytron homogenizer in RNAzol B (Biotecx Labs, Inc., Houston, TX) according to the manufacturer's recommendations. For each reaction, 1 pg of total RNA was reverse transcribed to cDNA using the GeneAmp preamplification system (Perkin Elmer Cetus, Norwalk, CT). The resulting cDNA was then subjected to 40 cycles of PCR using a DNA Thermal Cycler 480 (Perkin-Elmer Cetus, Norwalk, CT). "AmpliTaq" DNA polymerase (Perkin Elmer Cetus, Norwalk, CT), and primers for HGF, c-met, or actin were used. The HGF primers amplify a 690 base pair (bp) fragment. The sequences of the primers correspond to the sequence for HGF published by Miyazawa et al. (1989) and are as follows: HGF forward primer (bp + 7 IO), 5'-ATCAGACACCACACCGGCA-CAAAT-3'; HGF reverse primer (bp + 1400), 5'-GAAATAGGGCAA-TAATCCCAAGGAA-3'. The c-met primers amplify an 836 bp fragment. The sequences of the primers correspond to the sequence of c-met published by Chan et al. (1988) and are as follows: c-met forward primer (bp + 142), 5'-GCA-GAAACCCCCATCCAGAATGTC-3'; c-met reverse primer (bp + 978) 5'-GGCCCCTGGTTTACTGACATACGC-3'.
It has been previously shown that these primer pairs specifically amplify transcripts for HGF and c-met when present in both human and rat tissues (DeFrances et al., 1992) . Amplified products have been cloned and sequenced, confirming their identities. The identity of each PCR product has been confirmed by ligation into the pCR II vector (Invitrogen Corp., San Diego, CA) and sequencing using "Sequenase" (USB, Cleveland, OH). Human fl-actin primers purchased from Clontech Laboratories, Inc. (Palo Alto, CA) amplify an approximately 1000 bp fragment. These primers were included to ensure that RNA from each sample was intact. Reactions using each set of primers were performed for Schwann cell RNA in the absence of reverse transcriptase to ensure that no contamination with plasmid DNA or genomic DNA had occurred (data not shown). Also, reactions were carried out omitting RNA to ensure that primers were not contaminated with plasmid DNA. Human placental total RNA was included as a positive control for all primers.
After amplification and extraction using a one-step chloroform procedure, each sample was applied to a 1% agarose/ethidium bromide gel at 100 V. The resulting gel was photographed using UV illumination.
Preparation of dorsal root ganglion neuron-Schwann cell cocultures and Schwann cell proliferation. Preparation of embryonic rat neurons in coculture with Schwann cells has been described (Ratner et al., 1986) . After 2-3 weeks Schwann cells were added to the dorsal root ganglia neuron culture with or without anti-HGF antiserum. After 3 hr serumcontaining medium was substituted with a defined, serum-free medium (N2) with or without anti-HGFantiserum, and 'H-thymidine was added at 2 pCi/ml for 24 hr. Cultures were fixed, processed for autoradiography, stained with toluidine blue, and analyzed for percentage oflabeled cell nuclei. Dorsal root ganglion neuronal membrane extract was prepared as described in Ratner et al. (1988) . Neurojibrorna extracts and normal human nerve extracts were prepared as described in Method II in Ratner et al. (1990) . Aliquots were dialyzed against PBS for 5-6 hr and stored at -70°C prior to addition to Schwann cells.
Results

HGF is mitogenic.for
Schwann cells HGF consistently induced 2040-fold stimulation of DNA synthesis in Schwann cells in low-serum medium (less than 0.5% serum); half-maximal stimulation was obtained with HGF at concentrations 3-5 @ml with maximum at 10 rig/ml (Fig. 1A ). These concentrations are in the same range as those required to stimulate proliferation of rat hepatocytes in a serum-free medium . When fetal bovine serum (10%) was added to the Schwann cell proliferation assay, HGF stimulated a S-lo-fold increase in DNA synthesis with the same half-maximal and maximal stimulation concentrations as in low-serum medium (Fig. 1B) . The lower degree of stimulation can be explained by higher basal proliferation in 10% serum. As shown in Figure lA , at concentrations higher than 10 &ml the magnitude of HGF-stimulated Schwann cell proliferation declined in both low-and high-serum medium. This decrease was not a result of toxicity, as cell number in the cultures remained constant over the duration of the bioassay even at 20 &ml HGF (not shown). Thus, HGF is a novel growth factor for Schwann cells. HGF was added to rat Schwann cells in combination with forskolin. Under conditions tested, 1 PM forskolin alone stimulated DNA synthesis very slightly and dramatically potentiated the mitogenic effect of bFGF and TGF/3 (1 or 2) ( Fig. 2A,B) ; 5 FM forskolin inhibited the action of TGF& but synergized with FGF, corroborating previous results (data not shown) (Ridley et al., 1989; Davis and Stroobant, 1990) . In contrast, when added to Schwann cells in combination with HGF (5 &ml), 1 PM forskolin abolished the ability of HGF to stimulate Schwann cell proliferation (Fig. 3) ; 0.1 PM forskolin had no effect (not shown), while 0.5 PM forskolin gave half-maximal inhibition ( Fig. 2A) . Addition of TGFPl with either bFGF or PDGF results in the induction of DNA synthesis in Schwann cells (Davis et al., 199 1; Shubert, 1992) . We tested whether bFGF or TGFP synergize with HGFin stimulation ofschwann cell proliferation. Schwann cells were exposed to HGF (2 or 4 r&ml) in combination with bFGF (0.8 and 1.6 @ml) or TGFPl (2 r&ml); bFGF and TGFPl were additive with HGF on Schwann cell proliferation at the concentrations used. Neither bFGF nor TGFP potentiated or inhibited the action of HGF (Fig. 2AJ3 ).
HGF and c-met mRNA expression in neonatal rat Schwann cells We examined whether HGF and/or c-met mRNA are expressed in rat Schwann cells using the reverse transcriptase PCR. Total RNA was extracted from cultured Schwann cells, and reverse transcription and PCR were carried out as described in Materials and Methods. PCR products were fractionated on 1% agarose/ ethidium bromide gel (Fig. 4) . Expected amplified fragments of 690 base pairs for HGF (Fig. 4 , lane F), 836 base pairs for c-met (lane E) and approximately 1000 base pairs for human 8-actin (lanes G) were observed in the control experiments using human placenta RNA. No expression of HGF mRNA was found in Schwann cells (lane C); however, the message for c-met was present in both control and rat Schwann cell RNA preparations (lane B). The identity of the c-met transcripts were confirmed by sequencing of the PCR product (not shown).
Mitogen from dorsal root ganglion neurons is immunologically dlflerent from HGF Two different anti-HGF antisera blocked proliferation of Schwann cells stimulated by recombinant HGF. In control experiments to confirm the specificity of the antisera, neither anti-HGF antisera inhibited Schwann cell proliferation stimulated by bFGF, by TGFP, or by crude glial growth factor (not shown).
Neither anti-HGF antisera inhibited proliferation of Schwann cells in coculture with intact dorsal root ganglia neurons, even at 10 times higher concentrations of anti-HGF antisera than those used to inhibit proliferation of Schwann cells induced by HGF itself (Fig. 5 ). An anti-rabbit HGF and anti-human HGF antisera were used on the rat tissue preparation (dorsal root ganglia were prepared from rat embryos), the ability of the antibodies to recognize rat HGF was confirmed using normal rat serum; HGF has been shown to be present in rat serum in (0). Lanes E-G, RNA from human placenta, which expresses both HGF and c-met mRNA, using the following primers: c-met (E), HGF (F), and @-actin (G). The nature of the 0.27 kb band in lane Cis unknown and likely to represent a PCR artifact. Schwann cell RNA was also amplified in the absence of reverse transcriptase with each primer set to omit the possibility of plasmid/product contamination. Additionally, the primers were examined for plasmid/ product contamination by carrying out reactions in the absence of RNA. Both experiments showed no plasmid/product contaminations had occurred (not shown). This figure is a composite photograph of a single gel. measurable amounts (DeFrances et al., 1992) . Addition of normal rat serum to rat Schwann cells resulted in the stimulation of DNA synthesis; anti-HGF antiserum inhibited up to 70% of the mitogenic activity of normal rat serum. As it remained possible that HGF was bound to cell membranes in a conformation undetected by antibodies, we prepared membrane extracts from cultured rat dorsal root ganglia in order to get the mitogen in solubilized form. These extracts induced DNA synthesis in quiescent Schwann cells, but the mitogenic activity of these extracts was not inhibited by anti-HGF antisera. These data strongly argue against the idea of HGF (or HGF-like protein) being a required component of the axonal membrane mitogen.
HGF-like protein mitogenic for Schwann cells can be extracted from human neurojibromas To determine if HGF is present in and might contribute to mitogenic activity found in normal nerve or Schwann cell tumors, high salt extracts were prepared from two normal adult human nerves and from eight neurofibromas from NFl patients, dialyzed against PBS, and added to rat Schwann cells in the 3H-thymidine incorporation assay. Normal nerve and six of eight neurofibromas tested contained dose-dependent mitogenic activity for Schwann cells, confirming previous results (Ratner et Stimulation of SC proliferation in 10% rat serum was equivalent to that stimulated by 10 ng/nl HGF. Anti-human HGF antiserum (1:lOOO) partially inhibited the mitogenic effect of rat serum on Schwann cells. C, Anti-human HGF antiserum (1: 100) was added to cocultures of DRG neurons at the time of seeding with Schwann cells. Cultures were pulsed with )H-thymidine; after 24 hr cultures were fixed and subjected to autoradiography. Labelling index of Schwann cells in these cultures was 75%, identical to control cultures without antisera or in the presence of nonimmune sera. D, DRG neuronal extract was added to Schwann cells in the nresence or absence ofanti-rabbit HGFantiserum (1: 1000). TCAprecipitable counts were the same in the presence or absence of the antibody.
al., 1990; data not shown). Activity in normal nerve extracts and in all six active tumor extracts was inhibitable by anti-HGF (Fig. 6 ). Inhibition ranged from 60% to 97% of the total activity in two or three separate analyses of each extract using various doses of extract. Thus, HGF (or HGF-like protein) is a new Schwann cell mitogen present in normal adult nerve and in neurofibromas.
We also found that neurofibroma and normal nerve extracts contain mitogens potentiated by forskolin (Fig. 64 . Forskolin at concentrations of 0.5-S I.~M dramatically potentiated the activity of all extracts tested (Fig. 7) ; forskolin-stimulated activity was not inhibited by anti-HGF antibodies, suggesting that HGF did not contribute to the forskolin-stimulated activity in neurofibromas.
Discussion
We have shown that HGF is a potent mitogen for rat sciatic nerve Schwann cells. The ability to stimulate Schwann cell proliferation vigorously in low-serum medium (~0.5% serum) distinguishes HGF from other defined Schwann cell mitogens (Ratner et al., 1988; Ridley et al., 1989; Eccleston et al., 1990; Stewart et al., 1991; Hardy et al., 1992; Schubert, 1992) . HGF at concentrations above 10 rig/ml showed reduced ability to stimulate Schwann cell proliferation, in contrast to PDGF, TGF& and GGF, all of which are characterized by a sigmoidal doseresponse curve with a characteristic plateau of saturation (Ridley et al., 1989; Davis and Stroobant, 1990; Eccleston et al., 1990; Stewart et al., 199 1 ).
An important feature of HGF's mitogenic action is the effect of the CAMP-elevating agent forskolin on HGF induction of DNA synthesis in Schwann cells. In contrast to previously de-fined Schwann cell mitogens, HGF activity is abolished by 1 FM forskolin and lower concentrations of forskolin did not potentiate the activity. CAMP can modulate response of Schwann cells to mitogen by upregulating PDGF receptors (Weinmaster and Lemke, 1990) . It is possible that increasing CAMP downregulates c-met. Combination of HGF, TGF& and forskolin (1 FM) elicited the same mitogenic response as TGF/3 plus forskolin alone, suggesting that HGF induced DNA synthesis in Schwann cells was completely abolished and did not interfere with TGFPI forskolin-induced Schwann cell proliferation. We also did not observe an inhibitory effect of TGFfl on HGF-induced Schwann cell proliferation, although Zamegar and Michalopoulos (1989) showed that stimulation of DNA synthesis in rat hepatocytes by HGF is inhibited by TGFP.
It has been shown that axonal cell membranes contain an unidentified mitogen for Schwann cells Ratner et al., 1987) . Like HGF, this factor is heparin binding (Ratner et al., 1988) and active in the absence of serum or forskolin. Antisera that completely block the activity of HGF on Schwann cells failed to inhibit the mitogenic activity of neuronal membrane extracts or Schwann cell proliferation in neuron-Schwann cell cocultures, thought to mimic Schwann cell proliferation during development. Thus, HGF is unlikely to be a component of the Schwann cell proliferation that occurs in peripheral nerve development. This is consistent with the idea that axons elevate CAMP in Schwann cells, enabling response to many polypeptide growth factors; when in contact with axons, Schwann cells may be refractory to HGF. There is also no evidence for concentration of HGF in developing peripheral nerves during the period of maximal Schwann cell proliferation in developing rats (DeFrances et al., 1992) .
We did not detect HGF mRNA in rat Schwann cells, although HGF message and HGF are present in many tissues, including the brain (Tashiro et al., 1990; Zamegar et al., 1990; DeFrances et al., 1992) . Thus, it is unlikely that HGF serves as an autocrine Schwann cell growth factor, at least under the conditions tested. This is consistent with observations ofsonnenberg et al. (1993) , who found that no tissue studied contained HGF and c-met transcripts in the same cells.
Schwann cells are quiescent in normal adult nerve (Abercombie and Johnson, 1946) . We found that normal adult human nerve extracts contain HGF (or HGF-like protein). It is known that HGF may be stored or secreted by cells in an inactive form. Pro-HGF (including some commercially available preparations sold mostly as precursor) is not active on Schwann cells (data not shown). Injury has been shown to cause proteolytic activation of HGF precursor in liver and kidney (Miyazawa et al., 1994) . Thus, HGF may become available to Schwann cells after injury.
We have also shown that HGF is present in human neurofibromas, where it constitutes 60-97% of the Schwann cell mitogenic activity extracted from these tumors when assayed in the absence of forskolin. Other mitogens for Schwann cells are also detectable in neurofibromas: IGF-1 is present in neurofibromas (Hansson et al., 1988) and has been recently shown to be a mitogen for Schwann cells in the presence of forskolin (Schumacher et al., 1993) . We previously have found bFGF and an unidentified heparin-binding Schwann cell mitogen in neurofibromas (Ratner et al., 1990) . As HGF binds to heparin (Zarnegar et al., 1990) , it is likely that the previously unidentified heparin-binding, non-FGF mitogenic activity in these tumors is contributed by HGF or HGF-like protein. Mitogenic activity in neurofibroma extracts assayed in the presence of forskolin could not be inhibited by anti-HGF antibodies, corroborating the idea that non-HGF Schwann cell mitogens, including bFGF and IGF-1, are present in neurofibromas. Neurofibromas consist of up to 80% Schwann cells (Peltonen et al., 1988) , suggesting that Schwann cell proliferation is an important component of neurofibroma formation. It will be important to localize Schwann cell mitogens, and their receptors, within neurofibromas to determine what cells synthesize and secrete these growth factors in order to begin to analyze the relevance of specific growth factors to tumor formation. We have shown in two reports that HGF is present in measurable amounts in normal rat serum (DeFrances et al., 1992; Michalopoulos and Zamegar, 1992) and here that HGF is responsible for 70% of rat serum's mitogenic activity on Schwann cells. Thus, it is possible that HGF in neurofibromas is derived from blood (which also might be a source of other growth factors detectable in neurofibromas). It is possible that some NFl manifestations, including formation of neurofibromas, result from abnormal expression or distribution of HGF.
